Riskpilot← Back to searchSign inGet full accessElimo AB
ABActiveOrg 5565252128StockholmGeneral medical practice activities · NACE 8621Est. 19951 employees
Revenue 2025
SEK 2,4M
+2% vs 2024
EBITDA margin
33.4%
+92% vs 2024
Equity ratio
64.7%
Financial strength
Net profit 2025
SEK 402K
+74% vs 2024
| Revenue | SEK 2,4M | +2% |
| EBITDA | SEK 817K | +92% |
| Net profit | SEK 402K | +74% |
| Total assets | SEK 4,6M | +15% |
| Equity | SEK 3M | +11% |
| Employees | 1 | — |
Legal name
Elimo AB
Org number
5565252128
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 juli 1995
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att tillhandahålla medicinska tjänster, bolaget skall även bedriva handel med samt äga och förvalta fastigheter och därmed förenlig verksamhet.
Address
Stockholm
Phone
+4687231305
Email
office@luki.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 598 | 2 377 | 2 419 | 2 407 | 2 449 |
| Staff expenses | — | −34 | −580 | −1 036 | −874 |
| EBITDA | 2 110 | 1 848 | 1 093 | 425 | 817 |
| Depreciation & amort. | −7 | −7 | −42 | −42 | −137 |
| EBIT | 2 103 | 1 842 | 1 052 | 383 | 681 |
| Net financials | −25 | −1 | 20 | 21 | 6 |
| Profit before tax | 2 077 | 1 465 | 803 | 299 | 512 |
| Tax | −0 | −233 | −167 | −68 | −110 |
| Net profit | 2 077 | 1 232 | 636 | 232 | 402 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 615 | 4 566 | 4 761 | 3 995 | 4 589 |
| Equity | 3 515 | 3 210 | 3 146 | 2 667 | 2 969 |
| Long-term debt | 702 | 3 | 3 | 4 | 104 |
| Short-term debt | 397 | 977 | 968 | 574 | 591 |
| Total debt | 1 099 | 980 | 971 | 578 | 694 |
EBITDA margin
33.4%
This company
15.8%
Market median
+111% vs market
20212025
Equity ratio
64.7%
This company
38.2%
Market median
+69% vs market
20212025
Return on equity
13.5%
This company
18.4%
Market median
+27% vs market
20212025
Net profit margin
16.4%
This company
8.1%
Market median
+102% vs market
20212025
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20212025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LM Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Elimo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linus Mikael Nilsson | Audit | 0 companies |
| Ann Elisabeth Moor | Board of Directors | 0 companies |
| John Hol Michael Larsson | Deputy Board Member | 0 companies |